VNDA - Vanda slips after rejecting takeover offers
2024-06-20 07:01:38 ET
More on Vanda Pharmaceuticals
- Vanda Pharmaceuticals: Undervalued With Promising Pipeline And Acquisition Interest
- Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript
- Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much
- Vanda Pharmaceuticals gains as Future Pak raises offer to $8.50-$9 a share (update)
- Vanda Pharma surges on $8 a share takeover offer from Cycle Pharma (update)